Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSLLY | REGN | GILD | ||
| Company | Csl Ltd ADR | Regeneron Pharmaceuticals | Gilead Sciences Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 97.6000 | 1,054.00 | 68.30 | ||
| High | 97.7800 | 1,058.17 | 68.49 | ||
| Low | 97.3000 | 1,030.23 | 67.58 | ||
| Last | 97.6000 | 1,044.66 | 68.40 | ||
| Change | +0.0300 | -12.36 | -0.24 | ||
| % Change | +0.03% | -1.17% | -0.35% | ||
| Volume | 28,800 | 364,200 | 4,846,100 | ||
| 20-Day Average Volume | 29,995 | 476,210 | 9,328,090 | ||
| Previous Close | 97.5700 | 1,057.02 | 68.64 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 96.4684 | 1,034.79 | 66.52 | ||
| 20-Day Raw Stochastic | 72.52% | 61.38% | 60.19% | ||
| 20-Day Relative Strength | 59.18% | 61.18% | 54.59% | ||
| Weighted Alpha | +12.67 | +47.36 | -10.41 | ||
| Today's Opinion | 100% Buy | 100% Buy | 40% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 40% Sell | ||
| Last Month's Opinion | 72% Buy | 88% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.27% since 06/25/24 | -2.48% since 06/25/24 | -1.74% since 06/25/24 | ||
| Low | 95.7600 on 07/01/24 | 1,030.23 on 07/02/24 | 67.58 on 07/02/24 | ||
| High | 99.5100 on 07/01/24 | 1,075.30 on 06/26/24 | 70.23 on 06/26/24 | ||
| 1-Month | |||||
| %Chg | +3.55% since 05/31/24 | +6.58% since 05/31/24 | +6.43% since 05/31/24 | ||
| Low | 92.5600 on 06/12/24 | 979.26 on 06/03/24 | 62.69 on 06/18/24 | ||
| High | 99.5100 on 07/01/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 | ||
| 3-Month | |||||
| %Chg | +4.80% since 04/02/24 | +9.43% since 04/02/24 | -5.12% since 04/02/24 | ||
| Low | 85.9600 on 04/22/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 | ||
| High | 99.5100 on 07/01/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 | ||
| 6-Month | |||||
| %Chg | +0.76% since 01/02/24 | +15.43% since 01/02/24 | -17.83% since 01/02/24 | ||
| Low | 85.9600 on 04/22/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 | ||
| High | 99.5400 on 01/31/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 94,330,888 | 115,106,896 | 85,216,352 | ||
| Shares Outstanding, K | 966,505 | 110,186 | 1,245,853 | ||
| Annual Sales | 13,310,000,000 | 13,117,200,000 | 27,116,000,000 | ||
| Annual Net Income | 2,194,000,000 | 3,953,600,000 | 5,665,000,000 | ||
| Last Quarter Sales | N/A | 3,145,000,000 | 6,686,000,000 | ||
| Last Quarter Net Income | N/A | 722,000,000 | -4,170,000,000 | ||
| 60-Month Beta | 0.76 | 0.13 | 0.18 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 9.55 on 05/02/24 | -1.32 on 04/25/24 | ||
| Latest Earnings Date | 08/12/24 | 08/01/24 | 08/01/24 | ||
| Most Recent Dividend | 0.545 on 03/11/24 | N/A | 0.770 on 06/14/24 | ||
| Next Ex-Dividends Date | 03/11/24 | N/A | 06/14/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.48 | 17.03 | ||